Breast cancer highlights from 2023: Knowledge to guide practice and future research
Maria-Joao Cardoso,
Philip Poortmans,
Elżbieta Senkus,
Oreste D. Gentilini,
Nehmat Houssami
Affiliations
Maria-Joao Cardoso
Champalimaud Foundation Breast Unit, Lisbon, Portugal; University of Lisbon, Faculty of Medicine, Lisbon, Portugal; Corresponding author. Champalimaud Foundation Breast Unit, Lisbon, Portugal
Philip Poortmans
Department of Radiation Oncology, Iridium Netwerk, Wilrijk-Antwerp, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerp, Belgium
Elżbieta Senkus
Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland
Oreste D. Gentilini
Università Vita-Salute San Raffaele, Milano, Italy; IRCCS Ospedale San Raffaele, Milano, Italy
Nehmat Houssami
Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, NSW, Australia; Wiser Healthcare, The University of Sydney, Sydney, NSW, Australia
This narrative work highlights a selection of published work from 2023 with potential implications for breast cancer practice. We feature publications that have provided new knowledge immediately relevant to patient care or for future research. We also highlight guidelines that have reported evidence-based or consensus recommendations to support practice and evaluation in breast cancer diagnosis and treatment. The scope of selected highlights represents various domains and disciplines in cancer control, from prevention to treatment of early and advanced breast cancer.
